ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag cell molecular biology immunology funding cancer culture

Microfluidics: Biology’s Liquid Revolution
Laura Tran, PhD | Feb 26, 2024 | 8 min read
Microfluidic systems redefined biology by providing platforms that handle small fluid volumes, catalyzing advancements in cellular and molecular studies.
Image showing monoclonal antibody treatment
The Resilience of Monoclonal Antibodies and their Makers
Laura Tran, PhD | Mar 15, 2024 | 10+ min read
The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.
The Vaginal Microbiome is Finally Getting Recognized
Hannah Thomasy, PhD, Drug Discovery News | Sep 25, 2023 | 10+ min read
Vaginal dysbiosis has long been a taboo subject, but studying and optimizing the vaginal microbiome could be a game changer for women's health.
One Protein to Rule Them All
Shelby Bradford, PhD | Feb 28, 2024 | 10+ min read
p53 is possibly the most important protein for maintaining cellular function. Losing it is synonymous with cancer.
Immunology Leader Vincenzo Cerundolo Dies
Ashley Yeager | Jan 16, 2020 | 2 min read
The Oxford researcher’s work on lipid and peptide antigens revealed key mechanisms in inflammation, immunotherapy, and vaccination, which are being pursued in clinical trial treatments.
Funding Briefs
The Scientist Staff | Apr 15, 1990 | 3 min read
Wellcome Welcomes Visiting Professors Universities interested in hosting leading research scientists can tap the Burroughs Wellcome Fund. Each year, Wellcome Visiting Professorships in the Basic Medical Sciences are presented to 21 scientists - three each in physiology, biochemistry/molecular biology, pharmacology, pathology, nutrition, immunology, and cell biology - for visits of two to five days at U.S. institutions. The Wellcome Visiting Professors teach, confer with students and faculty,
Illustration of clear cells with orange nuclei, Toxoplasma gondii, on colorful background
Turning Toxoplasma Against Cancer
Annie Melchor | Jan 3, 2022 | 9 min read
Several research groups have found that Toxoplasma gondii infection can ramp up antitumor immune responses in mice. Can the single-cell parasite be used to develop safe treatments for humans?
Immunology
The Scientist Staff | Mar 17, 1991 | 2 min read
J.G. Bodmer, S.G.E. Marsh, E. Albert, "Nomenclature for factors of the HLA system, 1989," Immunology Today, 11, 3-10, January 1990. Julia Bodmer (Imperial Cancer Research Fund, London): "`What's in a name? That which we call a rose / By any other name would smell as sweet.' Shakespeare was right only in pointing out that it does not matter whether we call the flower a rose or a widget. The important thing is that we all call it by the same name. The 1989 nomenclature report is the ninth in a
Cancer cell
Interrogating the Complexities of the Tumor Microenvironment
Alison Halliday, PhD, Technology Networks | May 19, 2023 | 5 min read
Gaining a better understanding of the dynamic and reciprocal interactions between cancer cells and the tumor microenvironment is essential for improving patient diagnosis and treatment.
The Breakthrough Prize ?Trophy
2024 Breakthrough Prizes in Life Sciences
Danielle Gerhard, PhD | Sep 14, 2023 | 10 min read
This year’s Breakthrough Prizes honor advances in CAR T cancer therapies, cystic fibrosis, and Parkinson’s disease.

Run a Search

ADVERTISEMENT